Zusammenfassung
Die Plasma TSH, T3 und T4 Reaktion auf Stimulation mit dem synthetischen thyrotropin-releasing-hormone (TRH) wurde bei 24 jungen gesunden Erwachsenen nach intravenöser Stimulation mit 200 µg TRH und bei 25 gesunden jungen Erwachsenen nach oraler Stimulation mit 1–3 maliger Applikation von 40 mg TRH untersucht. Nach intravenöser Stimulation steigt die TSH Konzentration innert 30 min auf einen Maximalwert von im Mittel 11,7 µE/ml an. Der T3 Anstieg von 1,17auf 1,62 ng/ml nach 2 h ist statistisch signifikant aber im Einzeltest diagnostisch nicht verwertbar. Ein signifikanter Geschlechtsunterschied konnte in der vorliegenden Untersuchung weder für die TSH noch für die T3 Reaktion gefunden werden. Nach oraler Stimulation wird ein etwas höherer maximaler TSH Wert von 13,2 µE/ml 3 h nach der Applikation gefunden. Der T3 Anstieg auf 2,19 ng/ml ist statistisch signifikant und diagnostisch verwertbar. Die Zunahme der Thyroxinkonzentration nach 8 h oder 3 h nach der dritten TRH Dosis ist statistisch signifikant.
Die nach intravenöser Stimulation gefundenen Werte stimmen gut mit den bisherigen Ergebnissen in der Literatur überein. Während die Untersuchungen an größeren gesunden Kollektiven für die intravenöse Stimulation eher spärlich sind, fehlen sie für die orale Stimulation praktisch ganz. Dreimalige repetierte Stimulation mit je 40 mg TRH über 24 h ergeben nach der dritten Dosis eine geringere TSH Stimulation auf nur 5,8 µE/ml bei einer vergleichbaren Zunahme der T3 Konzentration.
Summary
TSH, T3 and T4 response to stimulation with thyrotropin releasing hormone (TRH) has been investigated in 24 young healthy adults after intravenous injection and in 25 young healthy adults upon oral application of 40 mg of TRH. After intravenous injection the TSH concentration raises from a mean of 1.6 to a mean maximum of 11.7µU/ml. A statistically significant sex difference could not be found. T3 shows a statistically significant increase which is however too small to be of diagnostic value in an individual test.
After oral stimulation with 40 mg of TRH, TSH rises to a slightly higher maximum of 13.2 µU/ml after 3 h. The T3 increase from 1.5 to 2.19 ng/ml is significant and considerably higher than after intravenous stimulation. The thyroxin increase is statistically significant.
The present results compare well with previously published data for intravenous stimulation. The oral route of TRH application has not yet been widely used and the present series establishes the normal response in young healthy adults.
Repetitive stimulation with three times 40 mg of TRH leads to a decrease in TSH stimulation which reaches 5.8 µU/ml 3 h after the third dose. This is in contrast to a comparable increase in plasma T3.
References
Azizi, F., Vagenakis, A.G., Portnay, G.I., Rapoport, B., Ingbar, S.H., Braverman, L.E.: Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing-hormone based on analyses of serum thyroxine, triiodo-thyronine and thyrotropin concentrations. New. Engl. J. Med.292, 273 (1975)
Beckers, C., Maskens, A., Cornette, C.: Thyrotropine responses to synthetic thyrotropin-releasing hormone in normal subjects and in patients with nontoxic goiter. Europ. J. clin. Invest.2, 220 (1972)
Besser, G.M., Mortimer, C.H.: Hypothalamic regulatory hormones: A review. J. clin. Path.27, 173 (1974)
Chopra, I.J., Chopra, U., Orgiazzi, J.: Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy. J. clin. Endocr.37, 955 (1973)
Clifton-Bligh, P., Silverstein, G.E., Burke, E.: Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease. J. clin. Endocr.38, 531 (1974)
Costom, B.H., Grumbach, M.M., Kaplan, S.L.: Effect of thyrotropin-releasing-factor on serum thyroid-stimulating hormone. An approach to distinguishing hypothalamic from pituitary forms of idiopathic hypopituitary dwarfism. J. clin. Invest.50, 2219 (1971)
Evered, D.: Disease of the thyroid gland. Clinics in Endocrin. and Metab.3, 425 (1974)
Faglia, G., Beck-Peccoz, P., Ambrosi, B., Ferrari, C., Neri, Y.: Prolonged and exaggerated elevations in plasma thyrotropin (HTSH) after thyrotropin-releasing factor (TRF) in patients with pituitary tumors. J. clin. Endocr.33, 999 (1971)
Faglia, G., Beck-Peccoz, P., Ferrari, C., Ambrosi, B., Spada, A., Travaglini, P., Paracchi, S.: Plasma thyrotropin response to thyrotropin-releasing-hormone in patients with pituitary and hypothalamic disorders. J. clin. Endocr.37, 595 (1973)
Faglia, G., Beck-Peccoz, P., Ambrosi, B., Ferrari, C., Travaglini, P.: The effect of a synthetic thyrotropin releasing hormone (TRH) in normal and endocrinopathic subjects. Acta endocrin.71, 209 (1972)
Faglia, G., Beck-Peccoz, P., Ferrari, C., Ambrosi, B., Spada, A., Travaglini, P.: Enhanced p-TSH response to TRH following oestradiol administration in men. Clin. Endocr.2, 207 (1973)
Fleischer, N., Lorente, M., Kirkland, J., Kirkland, R., Clayton, G., Calderon, M.: Synthetic TRH as a test of pituitary thyrotropin reserve. Journal of Clinical Endocrinology and Metabolism, 1972, Vo. 34, No. 4
Girard, J., Staub, J.J., Bühler, U., Nars, P.W., Stahl, M., Baumann, J.B.: TSH and T4 after stimulation with intravenous or oral TRH in children. Acta endocrin. 73, Suppl.177, 301 (1973)
Gordin, A., Saarinen, P., Pelkonen, R., Lamberg, B.A.: Serum thyrotropin and the response to thyrotropin releasing hormone in symptomless autoimmune thyroiditis and in borderline and overt hypothyroidism. Acta Endocrin.75, 274 (1974)
Haighler, E.D. Jr., Hershman, J.M., Pittman, J.A. Jr.: Response to orally administrated synthetic TRH in man. Journal of Clinical Endocrinology and Metabolism, 1972, Vol. 35, No. 5
Haigler, E.D. Jr., Pittmann, J.A. Jr. Hershman, J.M., Baugh, Ch.M.: Direct evaluation of pituitary thyrotropin reserve utilizing synthetic thyrotropin releasing hormone. J. clin. Endocr.33, 573 (1971)
Hall, R., Ormston, B.J., Besser, G.M., Cryer, R.J., McKendrick, M.: The thyrotropin-releasing-hormone-test in disease of the pituitary and hypothalamus. The LancetI, 759 (1972)
Hall, R., Werner, I., Holgate, H.: Thyrotropin-releasing-hormone Front. Hormone Res., I. Karger Basel (1972)
Hershman, J.M., Pittman, J.A.: Control of thyrotropin secretion in man. New Engl. J. Med.285, 997 (1971)
Job, J.C., Milhaud, G., Binet, E., Rivaille, P., Moukhtar, M.S.: Effet de l'hormone de libération de la thyréostimuline (TRH) sur le taux sanguin de thyréostimuline (TSH) chez l'enfant: Enfants normaux, enfants atteints d'hypothyréodie, h'hypopituitarisme, de goôtre. Eur. Etud. clin. Biol.16, 537 (1971)
Lawton, N.F., Ellis, S.M., Sufi, S.: The T3 and T4 response to TRH in the assessment of the pituitary-thyroid axis. Clin. Endocr.2, 57 (1973)
Lemarchand-Béraud, Th., Scazziga, B.R., Genazzani, A., Enderle, B., Burckhardt, F., Vannoti, A.: Réponse hypophysaire au TRH (thyrotropin releasing hormone) chez les sujets normaux. Schweiz. med. Wschr.103, 831 (1973)
Malvaux, P., Beckers, C.: Serum TSH response to TRH in normal children. Clin. Endocr.2, 219 (1973)
Ormston, B.J., Alexander, L., Evered, D.C., Clark, F., Bird, T., Appleton, D., Hall, R.: Thyrotrophin response to thyrotrophin-releasing hormone in ophthalmic Graves' disease — Correlation with other aspects of thyroid function, thyroid suppressibility and activity of eye signs. Clin. Endocr. (Eng.)2, 369 (1973)
Patel & Burger: Serum T3 in Health and Disease. Clinical Endocrinology35, 5 (1972)
Piva, F. & Steiner, H.: Bioassay and Toxicology of TRH. Animals Studies. Frontiers of hormone Research, Karger, Basel 1972
Powers, R., Wilber, J., Utiger, R., Montoya, E.: Thyrotropin (TSH) and prolactin (HPr) inhibition by endogenous thyroxine (T4) and triiodothyronine (T3) after sequential oral thyrotropin releasing hormone (TRH). Clin. Res.21, 866 (1973)
Rabello, M.M., Snyder, P.J., Utiger, R.D.: Effects on the pituitary-thyroid axis and prolactin secretion of single and repetitive oral doses of thyrotropin releasing hormone (TRH). J. clin. Endocr.39, 571 (1974)
Shenkman, L., Mitsuma, T., Hollander, C.S.: Modulation of pituitary responsiveness to thyrotropin-releasing hormone by triiodothyronin. J. clin. Invest.52, 205 (1973)
Staub, J.J.: Diagnostische Anwendung von TSH-Releasing-Hormon (TRH) Untersuchung der hypophysären TSH-Reserve mit radioimmunologischer Bestimmung des TSH vor und nach oralem und intravenösem TRH. Habilitationsschrift
Staub, J.J., Weiss, S., Kohler, H., Bürgi, H., König, M.P., Studer, H.: Effekt von peroral verabreichtem “TSH releasing hormone” (TRH) auf die Thyroxinkonzentration des Blutes. Schweiz. med. Wschr.101, 1295 (1971)
Torjesen, A., Haug, E., Sand, T.: Effect of TRH on serum levels of pituitary hormones in men and women. Acta Endocrinologica, 1973
Vagenakis, A.G., Rapoport, B., Azizi, F., Portnay, G.I., Braverman, L.E., Inbar, S.H.: Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations. J. clin. Invest.54, 913 (1974)
Wenzel, K.W., Meinhold, H., Herpich, M., Adlkofer, F., Schleusener, H.: TRH Stimulationstest mit alters- und geschlechtsabhängigem TSH-Anstieg bei Normalpersonen. Klin. Wschr.52, 722 (1974)
Zuppinger, K.A., Joss, E.E., König, M.P., Staub, J.J., Girard, J., Ehrengruber, H.: Effect of oral thyrotrophin-releasing hormone in serum thyroxine in growth hormone-deficient and normal children. Clin. Endocr.4, 119 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vogt, P., Girard, J. & Staub, J.J. Thyroid-stimulating hormone (TSH), triiodothyronine (T3) and thyroxine (T4) response to intravenous and oral stimulation with synthetic thyrotropin-releasing hormone (TRH) in young healthy adults. Klin Wochenschr 56, 31–35 (1978). https://doi.org/10.1007/BF01476740
Issue Date:
DOI: https://doi.org/10.1007/BF01476740